An eosinophil peroxidase activity assay predicts acute exacerbations in post-operative chronic rhinosinusitis.
chronic rhinosinusitis
endoscopic sinus surgery
eosinophil peroxidase
Journal
International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261
Informations de publication
Date de publication:
20 May 2024
20 May 2024
Historique:
revised:
18
04
2024
received:
11
03
2024
accepted:
05
05
2024
medline:
20
5
2024
pubmed:
20
5
2024
entrez:
20
5
2024
Statut:
aheadofprint
Résumé
EPX activity has been correlated with eCRS diagnosis and baseline disease severity. Herein, EPX activity is shown to correlate with post-operative antibiotic and steroid use in CRS. EPX activity has potential to act as a prognostic biomarker of CRS disease severity and control.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Institute of Allergy and Infectious Diseases
ID : 2R44AI126987
Organisme : National Institute of Allergy and Infectious Diseases
ID : 1R41AI179525
Organisme : Flight Attendant Medical Research Institute
ID : CIA160008
Organisme : National Center for Advancing Translational Sciences of the National Institutes of Health under Award Numbers
ID : UM1TR004409
Organisme : National Center for Advancing Translational Sciences of the National Institutes of Health under Award Numbers
ID : 1K12TR004413
Informations de copyright
© 2024 ARS‐AAOA, LLC.
Références
Saffari H, Leiferman KM, Clayton F, et al. Measurement of inflammation in eosinophilic esophagitis using an eosinophil peroxidase assay. Official J Am College Gastroenterol. 2016;111(7):933‐939.
Smith KA, Gill AS, Pollard CE, et al. An eosinophil peroxidase activity assay accurately predicts eosinophilic chronic rhinosinusitis. J Allergy Clin Immunol. 2023;152(2):400‐407.
Smith TL, Schlosser RJ, Mace JC, et al. Long‐term outcomes of endoscopic sinus surgery in the management of adult chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019;9(8):831‐841.
Hoy SM. Dupilumab: a review in chronic rhinosinusitis with nasal polyps. Drugs. 2020;80(7):711‐717.
Idler BM, Iijima K, Ochkur SI, et al. Eosinophil peroxidase: a biomarker for eosinophilic chronic rhinosinusitis agnostic of polyp status. Laryngoscope. 2024;134(1):69‐78.
Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1‐464.
Phillips KM, Speth MM, Shu ET, et al. Validity of systemic antibiotics and systemic corticosteroid usage for chronic rhinosinusitis as metrics of disease burden. Rhinology. 2020;58(3):194‐199.